MCPH1: A Novel Case Report and a Review of the Literature.
Stefano Giuseppe CaraffiMarzia PollazzonMuhammad FarooqAmbrin FatimaLars Allan LarsenRoberta ZuntiniManuela NapoliLivia GaravelliPublished in: Genes (2022)
Microcephaly primary hereditary (MCPH) is a congenital disease characterized by nonsyndromic reduction in brain size due to impaired neurogenesis, often associated with a variable degree of intellectual disability (ID). The genetic etiology of MCPH is heterogeneous and comprises more than 20 loci, nearly all following a recessive inheritance pattern. The first causative gene identified, MCPH1 or Microcephalin , encodes a centrosomal protein that modulates chromosome condensation and cell cycle progression. It is also involved in DNA damage response and telomere maintenance in the nucleus. Despite numerous studies on MCPH1 function, MCPH1-affected individuals are rare and the available clinical reports are not sufficient to define the natural history of the disease. Here, we present a novel patient with congenital microcephaly, ID, language delay, short stature, and other minor features such as strabismus. magnetic resonance imaging revealed ventriculomegaly, simplified gyral pattern in the frontal lobes, and a neuronal migration defect. Genetic testing detected a homozygous deletion of exons 1-8 of MCPH1 . We compare the patients' characteristics with a list of features from MCPH1 cases described in the literature, in an effort to provide additional clues for a comprehensive definition of disease presentation and evolution.
Keyphrases
- intellectual disability
- autism spectrum disorder
- cell cycle
- magnetic resonance imaging
- dna damage response
- zika virus
- end stage renal disease
- genome wide
- copy number
- chronic kidney disease
- systematic review
- cell proliferation
- newly diagnosed
- case report
- ejection fraction
- mitochondrial dna
- working memory
- computed tomography
- white matter
- multiple sclerosis
- single cell
- patient reported outcomes
- contrast enhanced
- amino acid
- transcription factor
- duchenne muscular dystrophy
- neural stem cells